Clinical and endoscopic response to ustekinumab in Crohn's disease: Week 16 interim analysis of the STARDUST trial

被引:0
|
作者
Danese, S. [1 ]
Vermeire, S. [2 ]
D'Haens, G. [3 ]
Panes, J. [4 ]
Dignass, A. [5 ]
Magro, F. [6 ,7 ]
Nazar, M. [8 ]
Le Bars, M. [9 ]
Sloan, S. [10 ]
Lahaye, M. [11 ]
Ni, L. [12 ]
Daperno, M. [13 ]
Lukas, M. [14 ]
Armuzzi, A. [15 ]
Lowenberg, M. [3 ]
Gaya, D. R. [16 ]
Peyrin-Biroulet, L. [17 ,18 ]
机构
[1] Humanitas Univ, Dept Gastroenterol, Milan, Italy
[2] Univ Hosp Leuven, Dept Gastroenterol, Leuven, Belgium
[3] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[4] Hosp Clin Barcelona CIBERehd, Dept Gastroenterol, Barcelona, Spain
[5] Agaples Markus Hosp, Dept Med 1, Frankfurt, Germany
[6] Univ Porto, Inst Mol & Cell Biol, Dept Pharmacol & Therapeut, Fac Med, Porto, Portugal
[7] Hosp Sao Joao, Dept Gastroenterol, Porto, Portugal
[8] Janssen Cilag Polska Sp Zoo, Med Affairs, Warsaw, Poland
[9] Janssen Cilag, Med Affairs, Issy Les Moulineaux, France
[10] Janssen Global Serv LLC, Med Affairs, Horsham, PA USA
[11] Janssen Cilag BV, Med Affairs, Breda, Netherlands
[12] Janssen Cilag Russia, Med Affairs, Moscow, Russia
[13] Mauriziano Hosp, Gastroenterol Unit, Turin, Italy
[14] Clin Ctr ISCARE, Clin & Res Ctr Inflammatory Bowel Dis, Prague, Czech Republic
[15] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, IBD Unit Presidio Columbus, Rome, Italy
[16] Glasgow Royal Infirm, Dept Gastroenterol, Glasgow, Lanark, Scotland
[17] Univ Lorraine, Univ Hosp Nancy, INSERM, Unite 954, Houdemont, France
[18] Dept Hepatogastroenterol, Houdemont, France
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP13
引用
收藏
页码:S049 / S052
页数:4
相关论文
共 50 条
  • [1] ENDOSCOPIC RESPONSE TO INDUCTION WITH USTEKINUMAB IN CROHN'S DISEASE: STARDUST INTERIM ANALYSIS
    Danese, Silvio
    Vermeire, Severine
    D'Haens, Geert R.
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Sloan, Sheldon
    Lahaye, Marjolein
    Ni, Lioudmila
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Lowenberg, Mark
    Gaya, Daniel R.
    Peyrin-Biroulet, Laurent
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1193 - S1194
  • [2] Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn's disease: Week 16 interim analysis of the STARDUST trial substudy
    Kucharzik, T.
    Wilkens, R.
    Maconi, G.
    D'Agostino, M. A.
    Le Bars, M.
    Nazar, M.
    Sloan, S.
    Lahaye, M.
    Ni, L.
    Ercole, E.
    Alloca, M.
    Machkova, N.
    Maaser, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S046 - S048
  • [3] INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL HEALING AFTER USTEKINUMAB INDUCTION IN CROHN'S DISEASE: WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL SUBSTUDY
    Kucharzik, Torsten
    Wilkens, Rune
    Maconi, Giovanni
    D'Agostino, Maria-Antonietta
    Le Bars, Manuela
    Nazar, Maciej
    Sloan, Sheldon
    Lahaye, Marjolein
    Ni, Lioudmila
    Ercole, Elena
    Allocca, Mariangela
    Machkova, Nadezda
    Maaser, Christian
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S61 - S61
  • [4] PHARMACOKINETICS, IMMUNOGENICITY, AND EXPOSURE-RESPONSE RELATIONSHIP OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE WEEK 16 INTERIM ANALYSIS OF THE STARDUST STUDY
    D'Haens, Geert R.
    Adedokun, Omoniyi J.
    Danese, Silvio
    Vermeire, Severine
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Gaya, Daniel R.
    Peyrin-Biroulet, Laurent
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S694 - S694
  • [5] Effect of maintenance ustekinumab on corticosteroid-free endoscopic and clinical outcomes in patients with Crohn's Disease - Week 48 analysis of the STARDUST trial
    Danese, S.
    Vermeire, S.
    D'Haens, G.
    Panes, J.
    Dignass, A.
    Magro, F.
    Nazar, M.
    Le Bars, M.
    Lahayel, M.
    Ni, L.
    Bravata, I.
    Gaya, D. R.
    Peyrin-Biroulet, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S032 - S033
  • [6] CLINICAL AND ENDOSCOPIC RESPONSE TO TREAT-TO-TARGET VERSUS STANDARD OF CARE IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB: WEEK 48 RESULTS OF THE STARDUST TRIAL
    Danese, Silvio
    Vermeire, Severine
    D'Haens, Geert R.
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Lavie, Frederic
    Bravata, Ivana
    Sloan, Sheldon
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Lowenberg, Mark
    Gaya, Daniel
    Peyrin-Biroulet, Laurent
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S25 - S25
  • [7] USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: RESULTS FROM A WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL
    Danese, Silvio
    Vermeire, Severine
    D'Haens, Geert
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Gaya, Daniel R.
    Peyrin-Biroulet, Laurent
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S409 - S409
  • [8] Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    D'Haens, Geert
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Bravata, Ivana
    Lavie, Frederic
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Loewenberg, Mark
    Gaya, Daniel R.
    Danese, Silvio
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 175 - 185
  • [9] CLINICAL AND ENDOSCOPIC OUTCOMES WITH USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE LONG-TERM EXTENSION PERIOD OF THE STARDUST TRIAL
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    D'Haens, Geert R.
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Bravata, Ivana
    Lavie, Frederic
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Lowenberg, Mark
    Gaya, Daniel R.
    Danese, Silvio
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S801 - S801
  • [10] Analysis of clinical features associated with favourable outcomes from ustekinumab treat-totarget strategy in Crohn's Disease patients in the STARDUST trial
    Danese, S.
    Vermeire, S.
    Dignass, A.
    Panes, J.
    D'Haens, G.
    Magro, F.
    Le Bars, M.
    Nazar, M.
    Lahaye, M.
    Ni, L.
    Bravata, I.
    Gaya, D. R.
    Peyrin-Biroulet, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S039 - S040